Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Erika Turkstra"'
Publikováno v:
PeerJ, Vol 3, p e1461 (2015)
Aims. The purpose was to evaluate the evidence for triple therapy regimen using medicines available in Australia for type 2 diabetes.Methods. A systematic literature review was performed to update the relevant evidence from 2002 to 2014 on triple the
Externí odkaz:
https://doaj.org/article/d5df6046ff1c4bf1b49628a342eab8a1
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:521-528
Objectives: The aim of this study was to examine submissions made to the Pharmaceutical Benefits Advisory Committee (PBAC) and assess whether the predicted financial impact was associated with a recommendation. The second objective was to assess whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa99b50f68f152cce759983e3578e50
https://doi.org/10.1017/s0266462317000617
https://doi.org/10.1017/s0266462317000617
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:3-4
IntroductionUltra-orphan therapies (prevalence: MethodsAll NICE HST technology guidance was screened (1 January 2013–6 November 2018) alongside corresponding guidance by Gemeinsamer Bundesausschuss (G-BA), Haute Autorité de Santé (HAS), Scottish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59141cdfa2e9c3dcc6c98b471fa7467e
https://doi.org/10.1017/s0266462319000916
https://doi.org/10.1017/s0266462319000916
Autor:
Paul Anthony Scuffham, Louisa G. Gordon, Andrew P. Hills, Erika Turkstra, Elizabeth Kendall, Tracy Comans, Jennifer A. Whitty, Joshua Byrnes, Nicole Moretto
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 11, Iss 3, Pp 2456-2471 (2014)
International Journal of Environmental Research and Public Health; Volume 11; Issue 3; Pages: 2456-2471
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health; Volume 11; Issue 3; Pages: 2456-2471
International Journal of Environmental Research and Public Health
Taxation has been suggested as a possible preventive strategy to address the serious public health concern of childhood obesity. Understanding the public’s viewpoint on the potential role of taxation is vital to inform policy decisions if they are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb871072a1176cb8b38456227f4d280
http://www.mdpi.com/1660-4601/11/3/2456
http://www.mdpi.com/1660-4601/11/3/2456
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:164-165
Introduction:In recent years, the National Institute for Health and Care Excellence (NICE) has increasingly agreed to reimburse innovative products with high levels of uncertainty as part of managed access agreements (MAAs) while new data are collect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d1dff3eccb8c0c287d84f35421d2bbe
https://doi.org/10.1017/s0266462318003446
https://doi.org/10.1017/s0266462318003446
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:118-119
Introduction:The pan-Canadian Oncology Drug Review (pCODR) was established in 2010 to bring consistent oncology drug assessments across Canadian provinces/territories. In April 2014, pCODR was transferred to the Canadian Agency for Drugs and Technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::059ba216e3574dbf908868a6c849ebb7
https://doi.org/10.1017/s0266462318002684
https://doi.org/10.1017/s0266462318002684
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:69-70
Introduction:In April 2017, the National Institute for Health and Care Excellence (NICE) updated its guidance for highly specialized technology (HST) appraisals, whereby it would automatically fund technologies for very rare diseases that fall below
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d608c6697695db72b5e1c1358804afa
https://doi.org/10.1017/s026646231800185x
https://doi.org/10.1017/s026646231800185x
Autor:
Erika Turkstra, R. Macaulay
Publikováno v:
International Journal of Technology Assessment in Health Care. 34:124-125
Introduction:Many countries use Health Technology Assessment (HTA) organizations to evaluate the clinical and economic impact of new therapeutic interventions. In some markets, HTA outcomes directly link to reimbursement decision-making based on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3261bf7bf21670e81db57fc53ab22e50
https://doi.org/10.1017/s0266462318002787
https://doi.org/10.1017/s0266462318002787
Publikováno v:
Current Medical Research and Opinion. 27:1885-1897
The short-term efficacy of biological disease modifying anti-rheumatic drugs (bDMARDs) for the treatment of established moderate to severe rheumatoid arthritis (RA) has been demonstrated by various randomized placebo or active treatment controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9478931668b2672d362206403a46dbd1
https://doi.org/10.1185/03007995.2011.608655
https://doi.org/10.1185/03007995.2011.608655
Publikováno v:
International Journal of Technology Assessment in Health Care. 35:54-54
IntroductionA range of innovative, targeted anti-cancer therapies have been developed over the past 20 years. More recently, companies have been developing combinations of these drugs. While this promises substantial efficacy benefits, dual-brand onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f61a3b59575b2cb589379517b9a0dd7
https://doi.org/10.1017/s0266462319002277
https://doi.org/10.1017/s0266462319002277